180 related articles for article (PubMed ID: 35002734)
1. Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients.
Ramirez-Perez S; Oregon-Romero E; Reyes-Perez IV; Bhattaram P
Front Pharmacol; 2021; 12():800220. PubMed ID: 35002734
[TBL] [Abstract][Full Text] [Related]
2. MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
Ramirez-Perez S; Vekariya R; Gautam S; Reyes-Perez IV; Drissi H; Bhattaram P
Arthritis Res Ther; 2023 Sep; 25(1):180. PubMed ID: 37749630
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor.
Ramírez-Pérez S; Hernández-Palma LA; Oregon-Romero E; Anaya-Macías BU; García-Arellano S; González-Estevez G; Muñoz-Valle JF
Molecules; 2020 Sep; 25(18):. PubMed ID: 32967164
[TBL] [Abstract][Full Text] [Related]
4. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825.
Liu M; Kang W; Hu Z; Wang C; Zhang Y
Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128
[TBL] [Abstract][Full Text] [Related]
5. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis.
Kim KW; Cho ML; Park MK; Yoon CH; Park SH; Lee SH; Kim HY
Arthritis Res Ther; 2005; 7(1):R139-48. PubMed ID: 15642134
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.
Boutet MA; Nerviani A; Lliso-Ribera G; Lucchesi D; Prediletto E; Ghirardi GM; Goldmann K; Lewis M; Pitzalis C
Rheumatology (Oxford); 2020 Apr; 59(4):828-838. PubMed ID: 31504934
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin treatment suppresses the proliferation, migration, invasion, and inflammatory responses of fibroblast-like synoviocytes from rheumatoid arthritis patients and attenuates synovial inflammation and joint destruction in CIA mice.
Lin W; Liu Y; Zhang S; Xu S; Qiu Q; Wang C; Liu D; Shen C; Xu M; Shi M; Xiao Y; Chen G; Xu H; Liang L
Int Immunopharmacol; 2023 Sep; 122():110502. PubMed ID: 37390648
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.
Wang F; Xu L; Feng X; Guo D; Tan W; Zhang M
Arthritis Res Ther; 2012 Oct; 14(5):R228. PubMed ID: 23078630
[TBL] [Abstract][Full Text] [Related]
9. Bulk and single cell transcriptomic data indicate that a dichotomy between inflammatory pathways in peripheral blood and arthritic joints complicates biomarker discovery.
Lee EJ; Lilja S; Li X; Schäfer S; Zhang H; Benson M
Cytokine; 2020 Mar; 127():154960. PubMed ID: 31881419
[TBL] [Abstract][Full Text] [Related]
10. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
11. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?
Cutolo M
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S26-31. PubMed ID: 14989426
[TBL] [Abstract][Full Text] [Related]
12. Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.
Andreas K; Häupl T; Lübke C; Ringe J; Morawietz L; Wachtel A; Sittinger M; Kaps C
Arthritis Res Ther; 2009; 11(1):R15. PubMed ID: 19192274
[TBL] [Abstract][Full Text] [Related]
13. RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.
Tongaonkar P; Punj V; Subramanian A; Tran DQ; Trinh KK; Schaal JB; Laragione T; Ouellette AJ; Gulko PS; Selsted ME
Physiol Genomics; 2019 Dec; 51(12):657-667. PubMed ID: 31762409
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood CD4
Gremese E; Tolusso B; Petricca L; Di Mario C; Gigante MR; Ferraccioli G; Alivernini S
Arthritis Res Ther; 2022 Jun; 24(1):143. PubMed ID: 35706043
[TBL] [Abstract][Full Text] [Related]
15. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
[TBL] [Abstract][Full Text] [Related]
16. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
[TBL] [Abstract][Full Text] [Related]
18. ST2825, a Small Molecule Inhibitor of MyD88, Suppresses NF-κB Activation and the ROS/NLRP3/Cleaved Caspase-1 Signaling Pathway to Attenuate Lipopolysaccharide-Stimulated Neuroinflammation.
Zhang SS; Liu M; Liu DN; Shang YF; Wang YH; Du GH
Molecules; 2022 May; 27(9):. PubMed ID: 35566338
[TBL] [Abstract][Full Text] [Related]
19. Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response.
Boutet MA; Nerviani A; Lliso-Ribera G; Leone R; Sironi M; Hands R; Rivellese F; Del Prete A; Goldmann K; Lewis MJ; Mantovani A; Bottazzi B; Pitzalis C
Front Immunol; 2021; 12():686795. PubMed ID: 34248970
[TBL] [Abstract][Full Text] [Related]
20. Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.
Alivernini S; Tolusso B; Gigante MR; Petricca L; Bui L; Fedele AL; Di Mario C; Benvenuto R; Federico F; Ferraccioli G; Gremese E
Sci Rep; 2019 Jul; 9(1):10420. PubMed ID: 31320744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
